These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Pharmacologic and therapeutic perspectives on calcium inhibitors]. Godfraind T Bull Mem Acad R Med Belg; 1982; 137(12):737-53. PubMed ID: 6309312 [No Abstract] [Full Text] [Related]
4. [Pharmacological analysis of a disorder in the mechanisms of coronary vessel reactivity in an experimental model of coronary insufficiency]. Lysenko LT; Trubetskoĭ AV Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(2):74-82. PubMed ID: 7317162 [TBL] [Abstract][Full Text] [Related]
8. Factors modifying the tissue selectivity of calcium-antagonists. Spedding M; Fraser S; Clarke B; Patmore L J Neural Transm Suppl; 1990; 31():5-16. PubMed ID: 1963634 [TBL] [Abstract][Full Text] [Related]
9. Calcium signal and calcium antagonists. Haiech J; Cavadore JC; Le Peuch C J Pharmacol; 1985; 16(3):215-25. PubMed ID: 2415777 [TBL] [Abstract][Full Text] [Related]
10. Acute hypertension and calcium-channel blockers. Kanneganti M; Halpern NA New Horiz; 1996 Feb; 4(1):19-25. PubMed ID: 8689271 [TBL] [Abstract][Full Text] [Related]
11. Effects of permeant ions and blockers on properties of single calcium channels from brains. Nelson MT Soc Gen Physiol Ser; 1987; 41():215-30. PubMed ID: 2436312 [No Abstract] [Full Text] [Related]
12. [Effects of magnesium and nicardipine in the cardioplegic solution on the coronary arteries and myocardium]. Shikano K; Nasu M; Miyamura K; Sakai T; Shomura S Rinsho Kyobu Geka; 1984 Sep; 4(5):556-60. PubMed ID: 6522980 [No Abstract] [Full Text] [Related]
13. Calcium movements, distribution, and functions in smooth muscle. Karaki H; Ozaki H; Hori M; Mitsui-Saito M; Amano K; Harada K; Miyamoto S; Nakazawa H; Won KJ; Sato K Pharmacol Rev; 1997 Jun; 49(2):157-230. PubMed ID: 9228665 [No Abstract] [Full Text] [Related]
14. Vasodilator mechanism of KB-944, a new calcium antagonist. Morita T; Kanazawa T; Ito K; Nose T Arzneimittelforschung; 1982; 32(9):1043-6. PubMed ID: 6890823 [TBL] [Abstract][Full Text] [Related]
15. Vasodilator action of calcium antagonists in coronary arteries in vitro. Kalsner S J Pharmacol Exp Ther; 1997 May; 281(2):634-42. PubMed ID: 9152367 [TBL] [Abstract][Full Text] [Related]
17. [Intracellular calcium messenger system and drug action]. Tanaka T; Nakatani K Nihon Rinsho; 1989 Aug; 47(8):1740-5. PubMed ID: 2585736 [No Abstract] [Full Text] [Related]
18. Evidence for the possible involvement of Ca2+ entry blockade in the relaxation by class I antiarrhythmic drugs in the isolated pig coronary smooth muscle. Tanaka Y; Kamibayashi M; Yamashita Y; Imai T; Tanaka H; Nakahara T; Ishii K; Shigenobu K Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):56-66. PubMed ID: 11862334 [TBL] [Abstract][Full Text] [Related]
19. [An in-vitro study of the sources of intracellular calcium in Ach-induced contractions and electrical depolarization and of the capacity of calcium antagonists to influence them in the canine detrusor]. Server Pastor G; Ruiz Cerdá JL; Osca García JM; Salom Sanvalero J; Jiménez Cruz JF Actas Urol Esp; 1996 Jan; 20(1):13-21. PubMed ID: 8720994 [TBL] [Abstract][Full Text] [Related]
20. Possible role of calcium ions, calcium channels and calmodulin in excystation and metacystic development of Entamoeba invadens. Makioka A; Kumagai M; Kobayashi S; Takeuchi T Parasitol Res; 2002 Sep; 88(9):837-43. PubMed ID: 12172816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]